ProgniaPrognia
Back to Articles
EndocrinologyMeta-analysis

Limited Comparative Evidence Between Metabolic Bariatric Surgery and Incretin-Based Pharmacotherapy for Weight Loss in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

4 August 2026·1 min read·Journal of diabetes

Abstract / Summary

Comparison of percentage total body weight loss (%TWL) between metabolic bariatric surgery and incretin-based pharmacotherapy in adults with type 2 diabetes mellitus. Forest plot showing pooled mean difference in percentage total body weight loss (%TWL) between treatment groups. Positive values favor metabolic bariatric surgery. Random-effects model with Hartung-Knapp adjustment was used.

Topics

HumansDiabetes Mellitus, Type 2Bariatric SurgeryWeight LossIncretins

Primary Source

Journal of diabetes

View Source

Ask Prognia AI

Have questions about this meta-analysis?

Prognia AI can search this source alongside 35M+ PubMed papers and current ESC, AHA, NICE, and ADA guidelines to give you a fully cited clinical answer.

Related Clinical Guidelines

Related Blog Posts